Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes
20 nov. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 20, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the first patient has been dosed in the expanded Part 1 of IMerge, the ongoing Phase 2/3...
Geron Announces November Investor Conference Presentation Webcasts
07 nov. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Third Quarter 2017 Financial Results
01 nov. 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and nine months ended September 30, 2017. For the third...
Geron Announces Presentations at American Society of Hematology Annual Meeting
01 nov. 2017 09h05 HE
|
Geron Corporation
MENLO PARK, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that four abstracts related to the telomerase inhibitor imetelstat have been accepted for...
Geron Announces Fast Track Designation Granted to Imetelstat for Lower Risk Myelodysplastic Syndromes
31 oct. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation to...
Geron Announces Conference Call to Discuss Third Quarter 2017 Financial Results
25 oct. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) will announce its financial results for the third quarter ended September 30, 2017, on Wednesday, November 1,...
Geron to Present at the Cantor Fitzgerald Healthcare Conference
19 sept. 2017 07h30 HE
|
Geron Corporation
MENLO PARK, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present at...
Geron Corporation Reports Second Quarter 2017 Financial Results
09 août 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2017. For the second quarter of...
Geron Announces Updates to Imetelstat Clinical Development
31 juil. 2017 19h00 HE
|
Geron Corporation
MENLO PARK, Calif., July 31, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today announced updates to the clinical development plans for IMerge and IMbark, the ongoing trials of the...
Geron Corporation Reports First Quarter 2017 Financial Results and Recent Events
09 mai 2017 16h05 HE
|
Geron Corporation
MENLO PARK, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq:GERN) today reported financial results for the first quarter ended March 31, 2017 and recent events. First Quarter...